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Purpose: The objectives of this study were to determine the time of onset, location, severity, 
rate of progression, and subsequent fate of infrainguinal vein graft lesions. 
Methods: Sixty-one infrainguinal vein grafts were studied serially with duplex ultrasonog- 
raphy to document the location and severity of each lesion. Grafts were studied at 1,2, 3, 
4, 6, 9, 12, and 18 months and then annually. 
Results: The cumulative secondary graft patency rate at 3 years (life-table analysis) was 
93.2%. A total of 158 lesions were detected in 55 of the 61 grafts studied. The degree of 
diameter reduction at the time of initial detection was as follows: 1% to 19% (29.6%), 20% 
to 49% (51.0%), 50% to 75% (17.3%), and greater than 75% (3.1%). Forty-eight percent 
were detected at the first examination, 59.2% within 2 months, and 85.7% within 6 
months. Progression was detected in31.2% of the lesions by 6 and in 39.1% of the lesions 
by 18 months (life-table analysis). Thrombosis, in the absence of significant changes in 
ankle-brachial index (> 0.15) or return of symptoms, was not observed in grafts that had 
lesions with less than 75% diameter reduction. 
Conclusions: The data support he performance of a duplex scan either during surgery or 
before discharge from the hospital in addition to frequent surveillance for the first 6 
months. Frequent surveillance is appropriate for lesions with less than 75% diameter 
reduction as long as they remain asymptomatic and without a significant reduction in the 
ankle-brachial index. (J VASe SURG 1995;22:466-75.) 
The natural history of infrainguinal vein grafts, 
including the anatomic distribution and time course 
of required revision for postimplantation stenosis, is 
of great clinical importance. 1-1° The published ata 
are not sufficient, however, for determining the 
optimal frequency ofnoninvasive surveillance and the 
indications for revision of vein grafts with specific 
lesions. Precise, prospective natural history data on 
vein graft lesions are needed to provide a rational 
basis for clinical decision making. 
Autogenous vein grafts develop particular prob- 
lems at definite time intervals. 1,n Failure in the 
perioperative period is attributable to undetected 
technical problems. Lesions that develop in the first 
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12 to 18 months are due to myointimal hyperplasia, 
which can progress rapidly once initiated} 2,13 It is 
possible that development of de novo lesions during 
this period may be uncommon and that most may be 
present at the time of surgery. TM I f  this is the case, 
those patients with early normal examination results 
may require less frequent subsequent surveillance. 
With knowledge of a lesion's true time of onset and 
expected rate of progression, we should be able to set 
the interval of postoperative duplex scanning accord- 
ing to need. 
Late graft failure (after 18 months) is believed to 
result from progression of disease in both the native 
vessels and the vein graft. It is not known whether the 
lower incidence of graft revision in the late period is 
related to a decreased incidence of lesions or greater 
lesion stability, nor do we know what factors may 
place some grafts at greater isk. 
The duplex scanning-derived velocity ratio (VR) 
across a lesion is the most accurate noninvasive 
parameter used to measure the degree of stenosis in 
vein grafts} s-17 These stenoses may be high grade, 
despite the absence of symptoms or significant 
change in the ankle-brachial index (ABI)} Mattos et 
al.10 have advocated repair of all asymptomatic vein 
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graft lesions with a VR greater than 2.0. Others have 
argued in favor of a less aggressive approach, with 
intervention reserved for lesions with a VR greater 
than 3.5 (in addition to those with significant ABI 
and graft flow-velocity reductions). 18The natural 
history of these "intermediate l sions" (VR 2.0 to 
3.5), including rates of progression and spontaneous 
graft thrombosis, in otherwise hemodynamically 
successful grafts is unknown. 
The objective of this study was to use a lesion- 
grading scheme that relies primarily on the VR to 
characterize the time of onset and rate of change in 
degree of stenosis in vein graft lesions. This infor- 
mation will have important implications for planning 
surveillance and therapy. 
MATERIAL AND METHODS 
In January 1992 we instituted an infrainguinal 
vein graft surveillance protocol that included duplex 
examinations at 1, 2, 3, 4, 6, 9, 12, and 18 months 
and then annually. Patient refusal to return for 
follow-up and permanent perioperative graft throm- 
bosis before the first duplex scan were the only 
reasons for exclusion from the study. Since that time, 
49 vein grafts have been enrolled in the study. An 
additional 12 grafts placed before January 1992 that 
had less frequent early follow-up (6-month intervals) 
were included for the analysis of late-lesion onset and 
new-lesion development after an intervention; how- 
ever, they were excluded from the analysis of early 
onset of primary lesions and rate of progression. 
Thirty-five of the grafts (57%) were performed 
for limb salvage, 20 for claudication (33%), three for 
popliteal artery aneurysm (5%), and three for trauma 
(5%). There were 46 reversed saphenous vein (75%), 
nine in situ saphenous vein (15%), three arm vein 
(5%), and three composite vein (5%) grafts. The 
distal anastomosis was placed at the following levels: 
above-knee popliteal artery in 18 (30%), below-knee 
popliteal artery in 22 (36%), and tibial artery in 21 
(34%) cases. 
Duplex scanning was performed with a Hewlett- 
Packard 1500 ultrasonic duplex scanner (Hewlett- 
Packard Co., Andover, Mass.). Three technologists 
were involved in the studies. A 7.5 MHz B-mode 
probe with a 5.5 MHz pulsed-wave Doppler flow 
detector was used for most portions of the graft; the 
deeper portions were scanned with a 4.5 MHz 
B-mode probe and a 3.5 MHz Doppler flow detec- 
tor. In most cases, velocity determinations were made 
at a 60-degree angle ofinsonation with respect to the 
long axis of the graft. If not technically feasible, the 
velocity was corrected according to the angle used. At 
Table I. Duplex scanning criteria used for 
defining stenoses is 
Diameter reduction Absolute veloci D, 
(%) VR (cm/sec) 
1-19 <2.0 PSV <150 
20-49 _>2.0 PSV < 150 
50-75 >2.5 PSV _>150 
> 75 _> 3.5 EDV _> 100 
PSV, Peak systohc velocity; EDV, end-diastohc velocity. 
each examination the entire graft was scanned includ- 
ing the inflow and outflow arteries. Velocity spectra 
were recorded from the inflow/outflow arteries, both 
anastomoses, and at seven sites within the graft, 
including stenoses. In nine cases an examination was 
performed before patient discharge from the hospi- 
tal. Two patients tmderwent intraoperative duplex 
scanning. When significant lesions were identified 
(>50% diameter reduction), the patients were 
monitored monthly until the lesion was believed to 
be stable. The resting ABI was measured at each visit, 
and a drop of greater than 0.15 from the highest 
postoperative alue was considered significant. 
Vein graft lesions were graded with a combina- 
tion of VRs and absolute velocities according to the 
method of Bandyk 18 (Table I). The VR is defined as 
the peak systolic velocity in the stenosis divided by 
the prestenotic peak systolic velocity. The degree of 
stenosis was graded solely on the VR, unless there 
was a large (two or more categories) discrepancy 
between the VR and the absolute velocity, in which 
case the lesion was assigned to an intermediate 
category. Assignment o the 1% to 19% stenosis 
category required both a B-mode abnormality (focal 
luminal narrowing or intimal thickening) and a 
velocity spectral abnormality (focal spectral broaden- 
ing or peak systolic velocity increased but < 150 
cm/sec with VR < 2.0). Intervention was performed 
on those lesions that led to either a return of 
symptoms, a reduction of the ABI of greater than 
0.15, or a greater than 75% diameter reduction. 
Primary lesions were defined as those detected 
after the initial operation. If a lesion was detected in 
a portion of a graft that had been revised, it was 
termed secondary. The time of lesion onset was 
defined as the time the stenosis was first identified. If 
a secondary lesion developed in a vein graft segment 
after a repair, its time of onset was measured relative 
to the time of revision. Lesions present at the first 
examination were classified as "residual," even 
though they may have developed in the short interval 
after surgery. De novo lesions were those detected 
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Fig. 1. Life-table analysis of primary, cumulative assisted primary, and cumulative s condary 
patency rates. Standard error was less than 10% for all plots through 3years. 
Table II. Causes of graft thrombosis* 
Time thrombosis ABI change Permanent 
Cause known ? (mo) Comment ( > 0.15) thrombosis ? 
No P Normal duplex No No 
No P Normal duplex No No 
No 28 Poor F/U ? No 
Yes 4 50%-75% VG lesion Yes No 
Yes 4 > 75% VG lesion No No 
Yes 5 > 75% VG lesion No Yes 
Yes 8 Several 50%-75% VG lesions Yes Yes 
Yes 12 Several 50%-75% VG lesions Yes Yes 
Yes 36 Outflow DZ Yes No 
P, Perioperative; F/U, follow-up; VG, vein graft; DZ, disease. 
%ix of the nine thromboses were salvaged and remain patent. 
after a normal initial examination result. Late onset of 
vein graft lesions was defined as initial detection after 
18 months. Progression/regression of a lesion was 
defined as a change to a higher or lower category of 
stenosis. 
The data were stored and analyzed with database 
management and spreadsheet systems (FoxPro and 
Excel; Microsoft Corp., Redmond, Wash.). The 
graft patency and lesion onset/progression/regres- 
sion/intervention data were analyzed by the life-table 
method. The outcome of lesions as a function of 
original degree of stenosis, location, and type of le- 
sion (residual vs de novo) were compared by the 
chi-squared test. 
RESULTS 
Graft patency. A total of 61 grafts were included 
in the study. The life-table analysis of graft patency is
plotted in Fig. 1. The values for primary, cumulative 
assisted primary, and cumulative secondary patency 
at 3 years were 44.2%, 76.9%, and 93.2%, respec- 
tively. Foot salvage was 95.0%. Overall, 32 primary 
repairs were performed on 21 grafts (34.4%). These 
included 14 patch angioplasties, ix balloon angio- 
plasties, five interposition grafts, four extension 
grafts, and three xcisions. Confirmatory angiograms 
were performed before 27 of these procedures 
(84.4%). Under no circumstances was the post- 
duplex management plan changed by the arterio- 
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gram. Nineteen (90.5%) of the 21 grafts remain 
patent and six (28.6%) have required additional 
procedures to maintain patency. We did not identify 
a significant change in the ABI before 10 (34.5%) of 
29 procedures. The causes of graft thrombosis are 
listed in Table II. Thrombosis, in the absence of 
significant ABI changes or symptoms, was not 
observed in grafts with VRs less than 3.5. 
Primary vein graft lesions. A total of 158 (141 
primary and 17 secondary) lesions were identified in 
55 (90.2%) of the 61 grafts, including the inflow and 
outflow vessels. There were 99 primary vein graft 
lesions in 50 grafts. Thirty-one of these grafts (62%) 
had multiple lesions per graft. The frequency of 
progression and revision for stenoses in grafts with 
multiple lesions is shown in Fig. 2. Progression and 
the requirement for revision in these conduits were 
usually either not seen at all or were seen at multiple 
sites. 
The anatomic distribution of the primary lesions 
and the percent that required interventions i  shown 
in Fig. 3. Lesions in the juxtaanastomotic vein graft 
were considered anastomotic. Anastomotic lesions 
were 1.17 times as prevalent as midgraft lesions, and 
proximal anastomotic lesions were 1.45 times as 
prevalent as distal anastomotic lesions. There were 
no statistically significant differences in rates of 
repair among vein graft locations, although there 
was a trend toward a greater need for intervention 
for proximal anastomotic lesions (31.2%). Seven 
(11.5%) of the 61 grafts required procedures on the 
native inflow or outflow vessels to maintain patency. 
Time of lesion onset. Ninety-eight vein graft 
lesions were identified in 46 grafts for the analysis of 
the time of lesion onset. The degree of diameter 
reduction for these lesions at the time of initial 
detection was as follows: 1% to 19% (29.6%), 20% 
to 49% (51.0%), 50% to 75% (17.3%), and greater 
than 75% (3.1%). Fig. 4 shows the cumulative 
distribution of the time of onset of these lesions. The 
time of initial detection was within 6 months in 
85.7% and within 2 months in 59.2% of the lesions. 
Vein graft lesions (of any initial severity) were 
detected in 83.1% of the grafts within 1 year and in 
60.0% of the grafts within 2 months (fife-table 
analysis). 
Fate of vein graft lesions. The fate of these same 
98 vein graft lesions from the time of onset hrough 
18 months (fife-table method) is plotted in Fig. 5. 
Both the rate of progression and the need for 
intervention plateaued at 6 months. Overall, regres- 
sion was more common than progression and was a 
Number 
of grafts 
0 1 >1 
Fig. 2. Frequency of lesion progression and revision in 31 
grafts with multiple lesions. 
frequent occurrence until 9 to 12 months after lesion 
onset. The occurrence of both progression and 
regression of the same lesion was noted for five of the 
stenoses (5.1%); all five progressed first and then 
regressed, and none required intervention. The 
specific 6-month and 1-year outcomes of these 
lesions, stratified according to severity of original 
lesion, are shown in Fig. 6. The lesions with less than 
50% stenosis frequently regressed, although some 
did progress and eventually require revision. At 6 
months, regression was less common in the lesions 
with greater than 50% stenosis (p < 0.05, chi-square 
test), and a significant proportion went on to require 
repair. 
A total of 30 vein graft lesions were identified 
during the study as 50% to 75% diameter reducing. 
Twenty-four of these (80%) were monitored for 
progression/regression andsix required revision be- 
cause they were associated with a significant reduc- 
tion in ABI. A total of 15 vein graft lesions were 
identified during the study as greater than 75% 
diameter reducing. Twelve (80%) were revised 
immediately. None of the remaining three was 
associated with a significant reduction in ABI and 
two of these patients had thrombosis of the grafts. 
One patient was awaiting surgery, and the other was 
not a candidate for surgery. The third patient has a 
lesion with a VR greater than 3.5 at a valve site. This 
patient is being monitored closely. 
Residual versus de novo lesions. Forty-seven of 
the 98 vein graft lesions were identified at the first 
examination (which was within 2 months in all 
patients and within 1 month in 75% of patients) and 
will be referred to as residual; 51 (52.0%) of the 98 
lesions developed after normal examination results 
and are thus de novo lesions. When the residual and 
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Fig. 3. Anatomic frequency distribution of 141 primary lesions detected. Percent requiring 
revision (Rx) is indicated for each location. (Prox., Proximal; Anas., anastomosis; Dst., distal.) 
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Fig. 4. Cumulative percent and frequency distribution of time of initial detection of vein graft 
lesion through 5 years (98 lesions in 46 grafts). 
de novo lesions were compared, there were signifi- 
cant differences in the degree of stenosis at first 
detection and the 6-month outcomes. Thirty-two 
percent of the residual lesions had greater than 50% 
narrowing at the time of detection versus 10% of the 
de novo lesions (p < 0.05, X 2 test). Progression and 
revision rates for lesions with similar degrees of 
original stenosis were higher for the residual lesions 
(Fig. 7), and these differences were statistically 
significant for the 20% to 4:9% category (20 < 0.05, 
chi-square test). 
I f  an abnormal graft is defined as having at least 
one vein graft lesion with a VR greater than 2.0, then 
20 of the 49 grafts with adequate early follow-up had 
abnormal initial examination results. Seven of these 
grafts (35%) went on to require revision of residual 
lesions. Four (13.8%) of the 29 grafts with normal 
initial examination results went on to require revision 
of de novo lesions. These revisions were required 3, 
4, 6, and 22 months after graft placement. 
Late follow-up. Late follow-up (past 18 months) 
was available for 25 (41.0%) of the 61 grafts. When 
followed out to 42 months, three graft revisions were 
required, two for progression of native vessel disease 
and one for a vein graft lesion that was first detected 
in the intermediate period and then progressed after 
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Fig. 5. Life-table analysis of incidence of progression, regression, and intervention i 98 vein 
graft lesions. Standard error was less than 10% for all plots through 18 months. 
18 months. A life-table analysis of the incidence of 
graft revision from 18 through 42 months yields a 
rate of 17.5% or an average of 8.8% per year during 
the late period. Nine vein graft lesions developed 
during the late period; four of the lesions developed 
in one graft, 17 months after a thrombectomy. The 
original stenoses were 1% to 19% in four and 20% 
to 49% in five grafts. Two of these lesions progressed, 
and none required revision during this period (al- 
though one required revision at 53 months). 
DISCUSSION 
Perhaps the most striking result in this study is the 
large proportion of grafts with detected lesions 
(90.2%). However, the proportion of grafts requir- 
ing revision and the patency rates are comparable to 
those in other reports. 3'7'8'1°,19 Most of these lesions 
were less than 50% diameter reducing (VR < 2.5), so 
it is important o understand the natural history of 
these lesions when monitored by serial duplex 
scanning. A large number of the sites with 1% to 19% 
diameter reduction are probably normal areas related 
to vein branching, tapering, and valve sinuses. 
However, 25% of these sites had progressed by 6 
months and three of five of these lesions required 
revision, so they are not all "normal." Perhaps the use 
of a threshold VR lower than 2.0 will allow us to 
differentiate between normal and abnormal areas 
with 1% to 19% diameter reduction. 
We also found a large proportion of grafts with 
multiple lesions. Lesion progression and the require- 
ment for revision were not evenly distributed among 
these grafts; they tended to occur in an all-or-none 
fashion, indicating that the disease may affect the 
entire graft. Progression of a lesion in a graft with 
multiple lesions is thus a marker; the remaining 
lesions appear to be at increased risk. 
Overall, about one fourth ( 26.5 %) of the primary 
lesions required repair. Lesions within the grafts 
required revision more frequently than those in the 
inflow or outflow arteries. A pooled analysis of recent 
reports indicates that midgraft lesions requiring 
revision are more common in in situ conduits, 1,4 
whereas anastomotic problems tend to predominate 
in reversed vein grafts, especially when the proximal 
juxtaanastomotic vein graft is considered part of the 
anastomosis. 2,3This is consistent with our findings. 
There were no significant differences in the propor- 
tion of lesions requiring revision between the three 
major vein graft sites (proximal and distal anastomo- 
sis, midgraft). The implication is that a given lesion's 
odds of requiring arevision (29.7%, 18 months after 
onset, life-table analysis) are not influenced by its 
location in the graft. 
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Fig. 6. SLx-month and 1-year outcome (degree ofstenosis or revision) of 98 vein graft lesions 
according to lesion severity at time of initial detection. At 6 months, incidence of regression was 
significantly less (7.1%) for lesions with 50% or greater diameter reduction than for those with 
less than 50% diameter reduction (37.5.0%) (p < 0.05, X 2 test). (Rx, Revision.) 
Most lesions appeared rapidly. Almost half the 
stenoses were evident at the first examination. Eigh- 
teen percent of the grafts required revision of 
potentially residual stenoses, and three grafts had 
lesions with VRs greater than 2.5 at the first visit. The 
data support further study of intraoperative duplex 
scanning in hopes of improving the primary patency 
rate. Intraoperative duplex scanning was used in only 
two patients in our study, and intraoperative angi- 
ography was used selectively, depending on the 
preference of the surgeon, the presence or absence of 
pulses, and the continuous-wave Doppler examina- 
tion after graft placement. It is possible that at least 
three of our grafts would have required intraopera- 
rive revision based on the VRs of the residual lesions 
at the first examination. 
We detected a high rate of de novo lesions, and 
many of these stenoses went on to require revision. 
Low rates of development of de novo lesions have 
been reported in studies that concentrated primarily 
on in situ grafts. 14 The differences with our results 
may reflect a biologic difference between reversed 
and in situ conduits. The in sire graft might be 
expected to have more residual midgraft lesions as a 
result of  unlysed valve cusps or intimal injury from 
the valvulotome, whereas the reversed conduit might 
be expected to develop neointimal hyperplasia de 
novo, especially near the anastomoses, because of size 
mismatch and flow disturbances. 
Most vein graft lesions have their onset during the 
first 6 months, and the majority of lesions that 
progress do so during the first 6 months after 
detection. The typical time course of vein graft failure 
and intervention, then, is a combination of these two 
separate vents (onset and progression), complicated 
by other factors such as the progression of native 
vessel disease, a slow but steady rate of development 
of late vein graft lesions, and a surprisingly high rate 
of lesion regression. The concept that neointimal 
hyperplastic lesions regress is not new and has been 
well described in a significant number of patients who 
undergo carotid artery restenosis after endarterecto- 
my? ° The vein graft lesion is a dynamic entity, 
especially during the first 6 to i2 months after 
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test). (Poe, Revision.) 
surgery. Progression and regression appear to be, for 
the most part, mutually exclusive. Lesions with 
greater degrees of stenosis at the time of detection are 
less prone to regression, and those with earlier times 
of onset (i.e., residual as opposed to de novo) appear 
to be more likely to progress and require revision. In 
the absence of an intraoperative study, duplex scan- 
ning performed before discharge from the hospital 
would be prudent o document the presence of these 
high-risk lesions. 
Thc frequency of vein graft surveillance practiced 
during the first 6-month interval varies considerably 
in both the community and academic centers, l°m 
Our data indicate that many grafts develop lesions 
that require therapy, both residual and de novo, 
within this period. Three grafts required revision of 
lesions at or before 6 months (one at 4, one at 5, and 
one at 6 months) that were not detected at the 
1-month examination. Examinations at 1, 3, and 6 
months would have been sufficient to detect these 
lesions and avoid graft thrombosis. After 6 months, 
the schedule should be open to modification depend- 
ing on the type of conduit and the status of existing 
lesions in the graft, including their time of onset, 
degree of stenosis, and recent history of progression 
or regression. A graft without any significant lesions 
at 6 months appears to be very "safe" and does not 
require frequent subsequent surveillance. 
It has been suggested that all lesions with VRs 
greater than 2.0 be repaired. 1° Our data would 
indicate that lesions with VRs less than 2.5 tend to 
have a relatively benign course. Most will either 
regress or remain unchanged. These lesions do, 
however, warrant careful surveillance, because about 
one third will progress and approximately one half of 
these will ultimately require therapy. There were no 
episodes of graft thrombosis caused by lesions of this 
severity. Management of lesions with VRs between 
2.5 and 3.5 are more controversial. In our study these 
lesions were less likely to regress and many required 
revision. Three of our patients had thrombosed grafts 
with lesions of this severity, but all had reductions in 
ABI of greater than 0.15 and were either awaiting or 
were not candidates for surgery. Our policy is to 
perform frequent surveillance on these lesions as long 
as they remain asymptomatic and without significant 
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reductions in ABI. I f  they remain stable for 3 to 6 
months, they are much less likely to require an 
intervention. Lesion length and absolute residual 
diameter may also be important considerations for 
stenoses o f  this severity. 6 Grafts with lesions that have 
greater than 75% diameter eduction are less contro- 
versial. They are at high risk for thrombosis and 
should, in general, be revised. 
Late graft revisions become necessary as a result o f  
three processes: (1) progression o f  native vessel 
disease; (2) late progression of  vein graft lesions that 
were detected early; and (3) late onset o f  vein graft 
lesions followed by progression. In our experience, 
late onset o f  vein graft lesions was not uncommon,  
but the lesions tended to have lower degrees o f  
narrowing and remained quite stable. Grafts that 
thrombose but are salvaged are possibly at increased 
risk o f  developing late de novo lesions, but our 
numbers were too small to test this hypothesis. The 
majority o f  late revisions were performed for pro- 
gression of  native vessel disease and, to a lesser extent, 
for progression o f  de novo lesions that were detected 
in the first months. The end result is a slow but steady 
incidence of  late graft revision. We continue to 
advocate yearly examinations for vein grafts without 
hemodynamically significant lesions after 18 months. 
The protocol for those grafts with stenoses i adjusted 
according to the characteristics o f  the individual 
lesions. 
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DISCUSSION 
Dr. J. Dennis Baker (Los Angeles, Calif.). This article 
presents an extensive investigation of lesions found in vein 
grafts in the leg. The study shows that a substantial 
proportion of lesions found may show regression in 
severity, similar to your findings with postoperative 
stenoses in the carotid artery. Many of you may be surprised 
by the fact that 90% of the grafts develop lesions; however, 
it must be realized that all degrees of stenosis are included. 
Only 20% of lesions were more than 50%, comparable to 
findings in other reports. A second similarity to previous 
work is the fact that a third of thromboses were unex- 
plained. 
Another datum that is surprising at first glance is the 
44% primary patency rate at 3 years. This appears to be a 
reflection of the aggressive approach to prophylactic repair, 
resulting in an assisted primary patency rate of 77%. 
Because this value is close to the primary patency rate 
reported by a number of authors, it raises the question as 
to whether too low a threshold for reoperation is being 
used. Can you comment on this? 
Forty-three percent of all operations resulted in grafts 
with lesions found at the first duplex scan, usually at 1 
month. This represents an important subset, because 
apparently nine of the 11 primary revisions were required 
in this group. It is likely that most of these lesions were 
present at operation, caused by either technical problems 
or bad veins. In view of the large size of this problem 
group, have you considered a more aggressive program 
of completion angiography or scanning? It would appear 
that reducing or eliminating this large group of problem 
cases at the time of the original operation would reduce 
the magnitude of postoperative follow-up and need for 
revision. 
The main concern I have with the article is the 
recommendation for monthly surveillance in the first 6 
months, because I do not find data to support the 
hypothesis. Although 86% of the lesions are detected 
within 6 months, there is no specific information on the 
time course of progression of lesions. It is not clear whether 
follow-up scans are obtained after a lesion reaches the 
greater than 75% category to see whether any regression 
occurs. If one were to eliminate the large number of 
residual lesions from the series, how important would early 
surveillance be? How many patients might develop a 
greater than 75% stenosis and for how long ifa completion 
study were performed uring surgery and the first scan was 
done at 6 months? Unless a significant number of graft sare 
at risk for a significant period, the recommendation,for 
frequent scans should not be made. 
Dr. Michael T. Caps. With regard to intraoperative 
studies, we performed intraoperative angiography On 
approximately one third of the grafts in the majority of the 
tibial artery bypasses and in the minority of the popliteal 
artery bypasses. We performed intraoperative duplex scan- 
ning on two patients. Your point is well taken that the high 
incidence of residual lesions that we found and their 
frequent need for revision would argue in favor of more 
intraoperative studies, which we are embarking on at the 
present ime. 
With regard to your comments on our primary patency 
rate of 44%, primary patency rates in the literature have 
ranged between mid-40% and approximately 70%, so 
although I agree with you that our rate is low, it is on the 
low end of values reported in the literature and does not 
indicate an excessively low threshold for surgery. 
You raised the question of whether angiography was 
performed after a lesion was detected to determine whether 
we were overcalling those lesions, and in about 85% of 
cases we did perform angiography before surgery, and in 
general we did not overcall these lesions. 
Dr. Wesley S. Moore (Los Angeles, Calif.). My 
concern is that you stated that this was going to be a natural 
history study. For it to fulfill the criteria of a natural history 
study, you would have to watch and wait until an event 
occurs (i.e., thrombosis) before you consider intervention. 
My understanding is that there was some threshold within 
your own clinical gestalt hat led you to intervene at some 
point, and I would be curious to know what that threshold 
was. 
Dr. Caps. Stenoses with diameter reduction of greater 
than 75 % are associated with a high risk of subsequent graft 
failure, and in our series there were a significant number 
that were not associated with decreases in the ankle-arm 
index of 0.15. 
Dr. Moore. So, if it reached 75% or greater, that was 
your indication for intervention? 
Dr. Caps. We actually have two lesions now that 
would fulfill the criterion of being greater than 75% 
diameter reducing. We have obtained angiograms on them. 
They appear to be normal valve leaflets with flow distur- 
bance, and we are not operating on them. 
Dr. Gregory L. Moneta (Portland, Ore.). I was 
interested in the observation that no grafts thrombosed 
without a decrease in ankle-arm index. Could you take this 
a little further and say, because the purpose of surveillance 
is not to detect lesions but to prevent hrombosis, if no 
grafts thrombosed without an increase in ankle-arm index, 
why do the surveillance? 
Dr. Caps. We did have two grafts that thrombosed 
with greater than 75% diameter reduction and no decrease 
in the ankle-arm index. This 'would argue in favor of 
surveillance, if anything. 
